Short answer
NEOGEN CORP (NEOG) filed its Q1 2026 10-Q quarterly report on Apr 9, 2026 for the quarter ended Feb 28, 2026. Quarterly revenue was $211M (down 4.4% year over year) with net income of −$17M.
Q1 2026 key financials · XBRL
- Revenue
- $211M
- −4.4% YoY · −6.0% QoQ
- Net income
- −$17M
- −55.3% YoY · −6.8% QoQ
- Operating margin
- -1.5%
- Gross margin
- 46.9%
- EPS (diluted)
- −$0.07
- −40.0% YoY · +12.5% QoQ
Source: XBRL data from the NEOGEN CORP (NEOG) Q1 2026 10-Q on SEC EDGAR. USD.
NEOGEN CORP Q1 2026 10-Q analysis
AI summary of MD&A and risk factor updates
Management Discussion & Analysis
- Revenue $211.2M, down $9.8M YoY, or 4.4%, primarily from divestitures and discontinued products
- Gross margin 46.9% vs 49.9% YoY; net loss $17.0M vs $10.9M
- Best segment Food Safety revenue $156.7M, up $3.9M; worst Animal Safety revenue $54.5M, down $13.7M
- Cash $159.9M; nine-month operating cash flow $53.0M vs $41.8M, while financing used $99.1M
- Outlook: Food Safety growth expected in calendar 2026; Animal Safety supplier issues anticipated into early fiscal 2027
- Fiscal 2026 capital expenditures estimated at approximately $50.0M, including $35.0M for 3M FSD integration
Risk Factors
- Executive equity dilution: 1,046,? total awards granted to newly hired executives in January 2026
- Inducement-award compliance: grants exempt from Securities Act registration under Section 4(2)
- Share-repurchase capacity: 5,900,000 shares remaining, with zero purchases during the quarter
- Insider trading risk: no director or officer adopted or terminated a Rule 10b5-1 arrangement during the quarter
Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K
Other NEOGEN CORP quarterly reports
Ask about this quarter
Compare quarters, check guidance or see what insiders and funds did around the report.